ProAgio Dose Levels (DL) 1,2,3,4
Sponsors
ProDa BioTech, LLC
Conditions
Pancreatic Ductal Adenocarcinoma (PDAC)Triple Negative Breast Cancer
Phase 1
ProAgio in Pancreatic Ductal Adenocarcinoma (PDAC)
RecruitingNCT06182072
Start: 2023-09-14End: 2028-06-30Target: 46Updated: 2025-10-01
ProAgio in Combination With Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer
RecruitingNCT06460298
Start: 2024-08-20End: 2027-10-01Target: 51Updated: 2026-08-31